CHCYX | VMGIX | CHCYX / VMGIX | |
Total Expense Ratio | 0.70 | 0.19 | 368% |
Annual Report Gross Expense Ratio | 0.71 | 0.19 | 374% |
Fund Existence | 29 years | 19 years | - |
Gain YTD | 3.673 | 13.334 | 28% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.6B | 32.3B | 8% |
Annual Yield % from dividends | 0.00 | 0.51 | - |
Returns for 1 year | 12.53 | 25.14 | 50% |
Returns for 3 years | 40.12 | 55.52 | 72% |
Returns for 5 years | -0.43 | 62.58 | -1% |
Returns for 10 years | 42.93 | 184.28 | 23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
VGM | 9.71 | 0.16 | +1.68% |
Invesco Trust Investment Grade Municipals | |||
IPB | 25.72 | 0.02 | +0.06% |
Merrill Lynch Depositor | |||
UJUN | 36.36 | -0.03 | -0.08% |
Innovator U.S. Equity Ultra BffrETF™-Jun | |||
CANQ | 29.41 | -0.04 | -0.15% |
Calamos Nasdaq® Equity & Income ETF |